Prostate Cancer Survivorship Essentials for Men with Prostate Cancer on Androgen Deprivation Therapy: Transforming Care to Improve Outcomes [ 9/1/2021 - 8/31/2025 ]

Research Grant

Brief description Up to half of all men diagnosed with prostate cancer will undergo androgen deprivation therapy (ADT) as part of their treatment at some point. Although ADT is effective in treating prostate cancer, many men will experience considerable side effects that negatively impact their quality of life. This research study will identify if a nurse-led survivorship care intervention, delivered by phone or video-call, improves the quality of life for men with prostate cancer who are receiving ADT.

Funding Amount $1,133,942

Funding Scheme Partnership Projects

Chief Investigator Prof Jeffrey Dunn

Notes Partnership Projects - 2nd call for 2020